Combination of PI3K and MEK inhibitors yields durable remission in PDX models of PIK3CA-mutated metaplastic breast cancers

Overview of attention for article published in Journal of Hematology & Oncology, February 2020

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (60th percentile)

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 2,345 followers.

RT @CellworksLife: Combination of PI3K and MEK inhibitors yields durable remission in PDX models of PIK3CA-mutated metaplastic #BreastCance…

RT @CellworksLife: Combination of PI3K and MEK inhibitors yields durable remission in PDX models of PIK3CA-mutated metaplastic #BreastCance…

Combination of PI3K and MEK inhibitors yields durable remission in PDX models of PIK3CA-mutated metaplastic #BreastCancers. https://t.co/h7fyf8nZYV

Combination of PI3K and MEK inhibitors yields durable remission in PDX models of PIK3CA - https://t.co/diU6IuMFZb #GoogleAlerts #breastcancer

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.